1. Home
  2. ALCO vs ABEO Comparison

ALCO vs ABEO Comparison

Compare ALCO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

N/A

Current Price

$40.61

Market Cap

293.7M

Sector

N/A

ML Signal

N/A

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$4.29

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALCO
ABEO
Founded
1960
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.7M
280.2M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
ALCO
ABEO
Price
$40.61
$4.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$44.00
$18.75
AVG Volume (30 Days)
26.6K
1.4M
Earning Date
05-12-2026
03-17-2026
Dividend Yield
0.50%
N/A
EPS Growth
N/A
165.16
EPS
N/A
1.01
Revenue
N/A
$2,998,000.00
Revenue This Year
N/A
$1,276.65
Revenue Next Year
N/A
$112.53
P/E Ratio
N/A
$4.29
Revenue Growth
N/A
258.18
52 Week Low
$27.61
$3.93
52 Week High
$43.20
$7.54

Technical Indicators

Market Signals
Indicator
ALCO
ABEO
Relative Strength Index (RSI) 55.54 32.62
Support Level $39.99 $4.00
Resistance Level $42.58 $5.62
Average True Range (ATR) 1.30 0.20
MACD 0.20 -0.05
Stochastic Oscillator 71.10 2.44

Price Performance

Historical Comparison
ALCO
ABEO

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: